Title: Ahmed Trad: Innovator in Antibody Humanization
Introduction
Ahmed Trad is a notable inventor based in the Czech Republic. He has made significant contributions to the field of biotechnology, particularly in the area of antibody humanization. His innovative approach aims to enhance the efficacy of therapeutic antibodies derived from rabbits.
Latest Patents
Ahmed Trad holds a patent titled "Method For Mass Humanization Of Rabbit Antibodies." This invention relates to a method for producing a population of 20 or more nucleic acids, each encoding at least one protein comprising at least one immunoglobulin variable domain. These domains have a rabbit-derived CDR3 amino acid sequence embedded in essentially human framework sequences. The patent also encompasses a population of nucleic acids and proteins related to this method, along with their various uses.
Career Highlights
Throughout his career, Ahmed Trad has worked with prominent companies in the biotechnology sector. He has been associated with Abcheck s.r.o. and Charles River Laboratories, Inc. His work in these organizations has contributed to advancements in antibody research and development.
Collaborations
Ahmed has collaborated with notable professionals in his field, including Jacob Gunn Glanville and Vera Molkenthin. These partnerships have further enriched his research and innovation efforts.
Conclusion
Ahmed Trad is a pioneering inventor whose work in antibody humanization has the potential to significantly impact therapeutic applications. His contributions to biotechnology continue to pave the way for future innovations in the field.